Filter
83
Text search:
selective
serotonin
reuptake
inhibitors
Featured
Recommendations
14
New Publications
12
Language
Document type
No document type
64
Guidelines
8
Manuals
5
Studies & Reports
4
Training Material
2
Countries / Regions
India
5
Global
2
Liberia
1
Nepal
1
South Sudan
1
Syria
1
Kenya
1
South Africa
1
Bangladesh
1
Singapore
1
Ukraine
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
11
Clinical Guidelines
8
Public Health
6
Women & Child Health
3
Capacity Building
1
Key Resources
1
Toolboxes
Mental Health
56
Pharmacy
4
COVID-19
2
Refugee
1
HIV
1
NCDs
1
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors
...
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors
...
Anxiety disorders
Chapter F.5
Abstract: Posttraumatic stress disorder (PTSD) is a chronic psychological disorder that can develop after exposure to a traumatic event. This review summarizes the literature on the epidemiology, assessment, and treatment of PTSD. We provide a review of the characteristics of PTSD along with associa
...
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake
...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap
...
Third edition
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK)
...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
Mood disorders
Chapter E.1
2015 edition
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
